tiprankstipranks
Trending News
More News >
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market

VYNE Therapeutics (VYNE) Balance Sheet

Compare
1,900 Followers

VYNE Therapeutics Balance Sheet

VYNE Therapeutics's total assets for Q3 2025 were $36.13M, a decrease of -19.20% from the previous quarter. VYNE total liabilities were $4.04M for the fiscal quarter, a -30.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 66.91M$ 97.69M$ 40.76M$ 67.05M$ 93.74M
Total Liabilities
$ 14.82M$ 8.95M$ 9.56M$ 18.41M$ 56.25M
Total Equity Gross Minority
$ 52.09M$ 88.73M$ 31.20M$ 48.64M$ 37.49M
Other Metrics
Currency in USD

VYNE Therapeutics Debt to Assets